Pages that link to "Q48343313"

The following pages link to HIV encephalitis, proviral load and dementia in drug users and homosexuals with AIDS. Effect of neocortical involvement (Q48343313):

Displayed 50 items.

• Kappa opioids promote the proliferation of astrocytes via Gbetagamma and beta-arrestin 2-dependent MAPK-mediated pathways (Q24643003) ‎ (← links)
• Estrogen protects against the synergistic toxicity by HIV proteins, methamphetamine and cocaine (Q24796371) ‎ (← links)
• Gonadal steroids differentially modulate neurotoxicity of HIV and cocaine: testosterone and ICI 182,780 sensitive mechanism (Q24813383) ‎ (← links)
• Interactions of Opioids and HIV Infection in the Pathogenesis of Chronic Pain (Q26768068) ‎ (← links)
• Genetic, transcriptomic, and epigenetic studies of HIV-associated neurocognitive disorder (Q26865707) ‎ (← links)
• Synergistic neurotoxicity of opioids and human immunodeficiency virus-1 Tat protein in striatal neurons in vitro (Q28354326) ‎ (← links)
• Morphine exacerbates HIV-1 Tat-induced cytokine production in astrocytes through convergent effects on [Ca(2+)](i), NF-kappaB trafficking and transcription (Q28474433) ‎ (← links)
• A growth factor attenuates HIV-1 Tat and morphine induced damage to human neurons: implication in HIV/AIDS-drug abuse cases (Q28477511) ‎ (← links)
• Modeling the Effects of Morphine on Simian Immunodeficiency Virus Dynamics (Q28554352) ‎ (← links)
• Rhesus macaque model of chronic opiate dependence and neuro-AIDS: longitudinal assessment of auditory brainstem responses and visual evoked potentials (Q30452156) ‎ (← links)
• Neuronal ferritin heavy chain and drug abuse affect HIV-associated cognitive dysfunction. (Q30569766) ‎ (← links)
• Alcoholism and AIDS: magnetic resonance imaging approaches for detecting interactive neuropathology (Q30712330) ‎ (← links)
• Morphine increases hippocampal viral load and suppresses frontal lobe CCL5 expression in the LP-BM5 AIDS model (Q33632272) ‎ (← links)
• Quantitation of parvalbumin+ neurons and human immunodeficiency virus type 1 (HIV-1) regulatory gene expression in the HIV-1 transgenic rat: effects of vitamin A deficiency and morphine (Q33653493) ‎ (← links)
• Effects of vitamin A deficiency and opioids on parvalbumin + interneurons in the hippocampus of the HIV-1 transgenic rat. (Q33754498) ‎ (← links)
• Fulminant encephalopathy with basal ganglia hyperintensities in HIV-infected drug users (Q33831555) ‎ (← links)
• Opioids and Opioid Maintenance Therapies: Their Impact on Monocyte-Mediated HIV Neuropathogenesis (Q33842214) ‎ (← links)
• Identification of shared populations of human immunodeficiency virus type 1 infecting microglia and tissue macrophages outside the central nervous system. (Q33850041) ‎ (← links)
• Opiates, immune system, acquired immunodeficiency syndrome, and nonhuman primate model. (Q33861574) ‎ (← links)
• Preclinical psychopharmacology of AIDS-associated dementia: lessons to be learned from the cognitive psychopharmacology of other dementias (Q34098757) ‎ (← links)
• Interactive HIV-1 Tat and morphine-induced synaptodendritic injury is triggered through focal disruptions in Na⁺ influx, mitochondrial instability, and Ca²⁺ overload. (Q34197724) ‎ (← links)
• HIV-1 Tat and opiate-induced changes in astrocytes promote chemotaxis of microglia through the expression of MCP-1 and alternative chemokines (Q34797566) ‎ (← links)
• HIV DNA reservoir increases risk for cognitive disorders in cART-naïve patients (Q34922069) ‎ (← links)
• HIV-1 infection in injection drug users (Q34950625) ‎ (← links)
• HIV-1 and morphine regulation of autophagy in microglia: limited interactions in the context of HIV-1 infection and opioid abuse (Q34990993) ‎ (← links)
• Interactions of HIV and drugs of abuse: the importance of glia, neural progenitors, and host genetic factors (Q35007339) ‎ (← links)
• HIV-1 neuropathogenesis: glial mechanisms revealed through substance abuse (Q35009465) ‎ (← links)
• Preferential vulnerability of astroglia and glial precursors to combined opioid and HIV-1 Tat exposure in vitro. (Q35009483) ‎ (← links)
• Glial-restricted precursors: patterns of expression of opioid receptors and relationship to human immunodeficiency virus-1 Tat and morphine susceptibility in vitro. (Q35019404) ‎ (← links)
• Sensitization of enteric neurons to morphine by HIV-1 Tat protein. (Q35236345) ‎ (← links)
• Cannabinoid neuroimmune modulation of SIV disease (Q35529056) ‎ (← links)
• Inhibition of EGF-induced ERK/MAP kinase-mediated astrocyte proliferation by mu opioids: integration of G protein and beta-arrestin 2-dependent pathways (Q35609910) ‎ (← links)
• Chronic SIV and morphine treatment increases heat shock protein 5 expression at the synapse (Q35650353) ‎ (← links)
• Editorial NeuroAIDS review (Q35731648) ‎ (← links)
• Behavioral, Metabolic, and Immune Consequences of Chronic Alcohol or Cannabinoids on HIV/AIDs: Studies in the Non-Human Primate SIV Model (Q35751830) ‎ (← links)
• Toll-like receptor expression and activation in astroglia: differential regulation by HIV-1 Tat, gp120, and morphine. (Q35779664) ‎ (← links)
• Disruption of gut homeostasis by opioids accelerates HIV disease progression (Q35782918) ‎ (← links)
• Morphine and gp120 toxic interactions in striatal neurons are dependent on HIV-1 strain (Q35857045) ‎ (← links)
• An update on the neuropathology of HIV in the HAART era. (Q35966034) ‎ (← links)
• Interactive Effects of Morphine on HIV Infection: Role in HIV-Associated Neurocognitive Disorder (Q35996523) ‎ (← links)
• Morphine efficacy is altered in conditional HIV-1 Tat transgenic mice. (Q36109980) ‎ (← links)
• Morphine modulation of toll-like receptors in microglial cells potentiates neuropathogenesis in a HIV-1 model of coinfection with pneumococcal pneumoniae (Q36157637) ‎ (← links)
• Opiate drug use and the pathophysiology of neuroAIDS. (Q36201412) ‎ (← links)
• The role of substance abuse in HIV disease progression: reconciling differences from laboratory and epidemiologic investigations. (Q36249104) ‎ (← links)
• The shifting patterns of HIV encephalitis neuropathology (Q36302049) ‎ (← links)
• Molecular targets of opiate drug abuse in neuroAIDS. (Q36302053) ‎ (← links)
• Morphine Tolerance and Physical Dependence Are Altered in Conditional HIV-1 Tat Transgenic Mice. (Q36432328) ‎ (← links)
• Nanoparticulate drug carriers for delivery of HIV/AIDS therapy to viral reservoir sites (Q36583732) ‎ (← links)
• Morphine exposure during HIV encephalitis in SCID mice (Q36687603) ‎ (← links)
• Neuropathologic contributions to understanding AIDS and the central nervous system (Q36771870) ‎ (← links)